Ganglion Cysts  >>  carbidopa/levodopa  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
carbidopa/levodopa / Generic mfg.
NCT00139867: A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease

Completed
3
US
PARCOPA
UCB Pharma
Parkinson's Disease
05/04
05/04
NCT00203164: Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Completed
3
254
US
rasagiline mesylate
Teva Branded Pharmaceutical Products R&D, Inc.
Parkinson's Disease
07/05
09/06
NCT00139880: A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease

Completed
3
US
Parcopa
UCB Pharma
Parkinson's Disease
08/05
08/05
NCT00203177: Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Completed
3
254
US, Canada
rasagiline mesylate, rasagiline mesylate 1.0 mg
Teva Branded Pharmaceutical Products R&D, Inc.
Parkinson's Disease
12/06
 

Download Options